1. Academic Validation
  2. Possible role of scavenger receptor SRCL in the clearance of amyloid-beta in Alzheimer's disease

Possible role of scavenger receptor SRCL in the clearance of amyloid-beta in Alzheimer's disease

  • J Neurosci Res. 2006 Sep;84(4):874-90. doi: 10.1002/jnr.20992.
Kenji Nakamura 1 Wakana Ohya Hiroshi Funakoshi Gaku Sakaguchi Akira Kato Masatoshi Takeda Takashi Kudo Toshikazu Nakamura
Affiliations

Affiliation

  • 1 Department of Biochemistry andMolecular Biology, Division of Molecular Regenerative Medicine, Osaka University Graduate School of Medicine, Osaka, Japan. [email protected]
Abstract

Accumulation of beta-amyloid protein (Abeta) in the brain is a hallmark of Alzheimer's disease (AD), and Abeta-mediated pathogenesis could result from increased production of Abeta or insufficient Abeta clearance by microglia, astrocytes, or the vascular system. Cell-surface receptors, such as scavenger receptors, might play a critical role in the binding and clearing of Abeta; however, the responsible receptors have yet to be identified. We show that scavenger receptor with C-type lectin (SRCL), a member of the scavenger receptor family containing coiled-coil, collagen-like, and C-type lectin/carbohydrate recognition domains, is expressed in cultured astrocytes and microglia. In contrast to the low expression of SRCL in the wild-type mouse brain, in a double transgenic mouse model of AD (Tg-APP/PS1), immunohistochemistry showed that SRCL was markedly induced in Abeta-positive astrocytes and Abeta-positive vascular/perivascular cells, which are associated closely with cerebral amyloid angiopathy. In patients with AD, the distribution of SRCL was similar to that seen in the Tg-APP/PS1 temporal cortex. The presence of a large number of SRCL/Abeta double-positive particles in the intracellular compartments of reactive astrocytes and vascular/perivascular cells in Tg-APP/PS1 mice and AD patients suggests a role for SRCL in Abeta clearance. Moreover, CHO-K1 cells transfected with SRCL isoforms were found to bind fibrillar Abeta(1-42). These findings suggest that SRCL could be the receptor involved in the binding or clearing of Abeta by glial and vascular/perivascular cells in AD.

Figures